{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:50:20Z","timestamp":1791838220046,"version":"4.3.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82474447"],"award-info":[{"award-number":["82474447"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82505802"],"award-info":[{"award-number":["82505802"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Cardiovasc Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The metabolic vulnerability index (MVX) captures metabolic-inflammatory vulnerability, but its joint relevance with Life\u2019s Essential 8 (LE8) for major adverse cardiovascular events (MACE) is unclear. We analyzed 239,135 UK Biobank participants free of baseline MACE. MVX was calculated from six NMR-based biomarkers. LE8 scores were classified as low (&lt;60), moderate (60\u201379), or high (\u226580) cardiovascular health (CVH). Cox models evaluated associations of MVX and LE8 with incident MACE; joint-effect, interaction, counterfactual, and mediation analyses were conducted. Over a median 13.6 years, 17,146 MACE occurred. Higher MVX was associated with higher MACE risk (HR\u2009=\u20091.08, 95% CI: 1.07, 1.10), whereas high CVH was associated with lower risk compared to low CVH (HR\u2009=\u20090.44, 95% CI: 0.41, 0.47). Participants with low CVH and MVX Q4 had the highest risk (HR\u2009=\u20092.84, 95% CI: 2.60, 3.12). Additive interaction was evident for MACE and myocardial infarction. Counterfactual and mediation analyses suggested that better CVH could prevent a substantial proportion of events, partly through lower metabolic vulnerability. Combined MVX and LE8 assessment may improve cardiovascular risk stratification and support targeted prevention.<\/jats:p>","DOI":"10.1038\/s44325-026-00139-0","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T16:06:03Z","timestamp":1781280363000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Metabolic vulnerability index and Life\u2019s Essential 8 with risk of major adverse cardiovascular events"],"prefix":"10.1038","volume":"3","author":[{"given":"Xiaojie","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y. H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junguo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"139_CR1","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jchf.2023.06.013","volume":"12","author":"KM Conners","year":"2024","unstructured":"Conners, K. M. et al. The metabolic vulnerability index: a novel marker for mortality prediction in heart failure. JACC Heart Fail. 12, 290\u2013300 (2024).","journal-title":"JACC Heart Fail."},{"key":"139_CR2","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1042\/CS20220797","volume":"138","author":"J Toto\u0144-\u017bura\u0144ska","year":"2024","unstructured":"Toto\u0144-\u017bura\u0144ska, J., Mikolajczyk, T. P., Saju, B. & Guzik, T. J. Vascular remodelling in cardiovascular diseases: hypertension, oxidation, and inflammation. Clin. Sci. 138, 817\u2013850 (2024).","journal-title":"Clin. Sci."},{"key":"139_CR3","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1016\/S2666-7568(23)00001-6","volume":"4","author":"JD Otvos","year":"2023","unstructured":"Otvos, J. D. et al. Multimarkers of metabolic malnutrition and inflammation and their association with mortality risk in cardiac catheterisation patients: a prospective, longitudinal, observational, cohort study. Lancet Healthy Longev. 4, e72\u2013e82 (2023).","journal-title":"Lancet Healthy Longev."},{"key":"139_CR4","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.3390\/nu17111747","volume":"17","author":"SK Kunutsor","year":"2025","unstructured":"Kunutsor, S. K. et al. Associations of multimarkers of metabolic malnutrition and inflammation with all-cause mortality by multimorbidity status. Nutrients 17, 1747 (2025).","journal-title":"Nutrients"},{"key":"139_CR5","first-page":"1","volume":"00","author":"R Xie","year":"2025","unstructured":"Xie, R. Metabolomics data improve 10-year cardiovascular risk prediction with the SCORE2 algorithm for the general population without cardiovascular disease or diabetes. Eur. J. Prevent. Cardiol. 00, 1\u201310 (2025).","journal-title":"Eur. J. Prevent. Cardiol."},{"key":"139_CR6","doi-asserted-by":"publisher","first-page":"640","DOI":"10.3390\/nu17040640","volume":"17","author":"TR Wicks","year":"2025","unstructured":"Wicks, T. R. et al. Endogenous ketone bodies are associated with metabolic vulnerability and disability in multiple sclerosis. Nutrients 17, 640 (2025).","journal-title":"Nutrients"},{"key":"139_CR7","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1161\/CIR.0000000000001078","volume":"146","author":"DM Lloyd-Jones","year":"2022","unstructured":"Lloyd-Jones, D. M. et al. Life\u2019s essential 8: updating and enhancing the American Heart Association\u2019s construct of cardiovascular health: a presidential advisory from the American Heart Association. Circulation 146, e18\u2013e43 (2022).","journal-title":"Circulation"},{"key":"139_CR8","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1093\/eurjpc\/zwad179","volume":"30","author":"J Zhang","year":"2023","unstructured":"Zhang, J. et al. Relation of Life\u2019s Essential 8 to the genetic predisposition for cardiovascular outcomes and all-cause mortality: results from a national prospective cohort. Eur. J. Prevent. Cardiol. 30, 1676\u20131685 (2023).","journal-title":"Eur. J. Prevent. Cardiol."},{"key":"139_CR9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s44325-026-00117-6","volume":"3","author":"K Yerabolu","year":"2026","unstructured":"Yerabolu, K. et al. Cardiovascular health in pregnancy according to Life\u2019s Essential 8 score. npj Cardiovasc. Health 3, 18 (2026).","journal-title":"npj Cardiovasc. Health"},{"key":"139_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-025-02619-1","volume":"24","author":"J Guo","year":"2025","unstructured":"Guo, J. et al. Central adiposity indices and inflammatory markers mediate the association between life\u2019s crucial 9 and periodontitis in US adults. Lipids Health Dis. 24, 199 (2025).","journal-title":"Lipids Health Dis."},{"key":"139_CR11","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1001\/jamacardio.2025.0630","volume":"10","author":"J Walker","year":"2025","unstructured":"Walker, J. et al. Cumulative Life\u2019s Essential 8 scores and cardiovascular disease risk. JAMA Cardiol. 10, 649\u2013656 (2025).","journal-title":"JAMA Cardiol."},{"key":"139_CR12","doi-asserted-by":"publisher","first-page":"101092","DOI":"10.1016\/j.molmet.2020.101092","volume":"42","author":"A Deprince","year":"2020","unstructured":"Deprince, A., Haas, J. T. & Staels, B. Dysregulated lipid metabolism links NAFLD to cardiovascular disease. Mol. Metab. 42, 101092 (2020).","journal-title":"Mol. Metab."},{"key":"139_CR13","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41392-024-01954-6","volume":"9","author":"T Hu","year":"2024","unstructured":"Hu, T. et al. Metabolic regulation of the immune system in health and diseases: mechanisms and interventions. Signal Transduct. Target Ther. 9, 268 (2024).","journal-title":"Signal Transduct. Target Ther."},{"key":"139_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1001\/jamadermatol.2024.4433","volume":"161","author":"A Svedbom","year":"2025","unstructured":"Svedbom, A. et al. Skin inflammation, systemic inflammation, and cardiovascular disease in psoriasis. JAMA Dermatol 161, 81\u201386 (2025).","journal-title":"JAMA Dermatol"},{"key":"139_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02711-x","volume":"24","author":"XR Zhang","year":"2025","unstructured":"Zhang, X. R. et al. Improved prediction and risk stratification of major adverse cardiovascular events using an explainable machine learning approach combining plasma biomarkers and traditional risk factors. Cardiovasc. Diabetol. 24, 153 (2025).","journal-title":"Cardiovasc. Diabetol."},{"key":"139_CR16","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1093\/eurjpc\/zwae124","volume":"31","author":"P Royer","year":"2024","unstructured":"Royer, P. et al. Large-scale plasma proteomics in the UK Biobank modestly improves prediction of major cardiovascular events in a population without previous cardiovascular disease. Eur. J. Prevent. Cardiol. 31, 1681\u20131689 (2024).","journal-title":"Eur. J. Prevent. Cardiol."},{"key":"139_CR17","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1161\/CIRCULATIONAHA.120.044221","volume":"143","author":"A Rohatgi","year":"2021","unstructured":"Rohatgi, A., Westerterp, M., von Eckardstein, A., Remaley, A. & Rye, K. A. HDL in the 21st century: a multifunctional roadmap for future HDL research. Circulation 143, 2293\u20132309 (2021).","journal-title":"Circulation"},{"key":"139_CR18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.pcad.2023.03.001","volume":"79","author":"M Banach","year":"2023","unstructured":"Banach, M. et al. Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP). Prog. Cardiovasc. Dis. 79, 2\u201311 (2023).","journal-title":"Prog. Cardiovasc. Dis."},{"key":"139_CR19","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1080\/15548627.2025.2474603","volume":"21","author":"X Zhang","year":"2025","unstructured":"Zhang, X. et al. Leucine accelerates atherosclerosis through dose-dependent MTOR activation in macrophages. Autophagy 21, 1618\u20131620 (2025).","journal-title":"Autophagy"},{"key":"139_CR20","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.atherosclerosis.2022.04.026","volume":"350","author":"Y Wang","year":"2022","unstructured":"Wang, Y. et al. Association of circulating branched-chain amino acids with risk of cardiovascular disease: a systematic review and meta-analysis. Atherosclerosis 350, 90\u201396 (2022).","journal-title":"Atherosclerosis"},{"key":"139_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004135","volume":"20","author":"T Geng","year":"2023","unstructured":"Geng, T. et al. Healthy lifestyle behaviors, mediating biomarkers, and risk of microvascular complications among individuals with type 2 diabetes: a cohort study. PLoS Med. 20, e1004135 (2023).","journal-title":"PLoS Med."},{"key":"139_CR22","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1093\/eurheartj\/ehad170","volume":"44","author":"PL Valenzuela","year":"2023","unstructured":"Valenzuela, P. L. et al. Exercise benefits in cardiovascular diseases: from mechanisms to clinical implementation. Eur. Heart J. 44, 1874\u20131889 (2023).","journal-title":"Eur. Heart J."},{"key":"139_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04062-1","volume":"21","author":"M Niu","year":"2023","unstructured":"Niu, M. et al. Emerging healthy lifestyle factors and all-cause mortality among people with metabolic syndrome and metabolic syndrome-like characteristics in NHANES. J. Transl. Med. 21, 239 (2023).","journal-title":"J. Transl. Med."},{"key":"139_CR24","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1161\/ATVBAHA.123.319290","volume":"43","author":"X Li","year":"2023","unstructured":"Li, X., Ma, H., Wang, X., Feng, H. & Qi, L. Life\u2019s essential 8, genetic susceptibility, and incident cardiovascular disease: a prospective study. Arteriosc. Thromb. Vasc. Biol. 43, 1324\u20131333 (2023).","journal-title":"Arteriosc. Thromb. Vasc. Biol."},{"key":"139_CR25","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S0140-6736(10)60834-3","volume":"376","author":"MJ O\u2019Donnell","year":"2010","unstructured":"O\u2019Donnell, M. J. et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 376, 112\u2013123 (2010).","journal-title":"Lancet"},{"key":"139_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-021-01440-5","volume":"21","author":"E Bosco","year":"2021","unstructured":"Bosco, E., Hsueh, L., McConeghy, K. W., Gravenstein, S. & Saade, E. Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review. BMC Med. Res. Methodol. 21, 241 (2021).","journal-title":"BMC Med. Res. Methodol."},{"key":"139_CR27","doi-asserted-by":"publisher","first-page":"6885","DOI":"10.1097\/JS9.0000000000002831","volume":"111","author":"J Zhang","year":"2025","unstructured":"Zhang, J. et al. The role of life\u2019s essential 8 and multimorbidity in the risk of new-onset atrial fibrillation: observations from a large prospective cohort study. Int. J. Surg. 111, 6885\u20136893 (2025).","journal-title":"Int. J. Surg."},{"key":"139_CR28","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"B Sun","year":"2023","unstructured":"Sun, B. et al. Plasma proteomic associations with genetics and health in the UK Biobank. Nature 622, 329\u2013338 (2023).","journal-title":"Nature"},{"key":"139_CR29","doi-asserted-by":"publisher","first-page":"e576","DOI":"10.1016\/S2468-2667(18)30200-7","volume":"3","author":"HME Foster","year":"2018","unstructured":"Foster, H. M. E. et al. The effect of socioeconomic deprivation on the association between an extended measurement of unhealthy lifestyle factors and health outcomes: a prospective analysis of the UK Biobank cohort. Lancet Public Health 3, e576\u2013e585 (2018).","journal-title":"Lancet Public Health"},{"key":"139_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43064-x","volume":"14","author":"C Ding","year":"2023","unstructured":"Ding, C. et al. Binge-pattern alcohol consumption and genetic risk as determinants of alcohol-related liver disease. Nat. Commun. 14, 8041 (2023).","journal-title":"Nat. Commun."}],"container-title":["npj Cardiovascular Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44325-026-00139-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44325-026-00139-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44325-026-00139-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T08:42:32Z","timestamp":1786437752000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44325-026-00139-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["139"],"URL":"https:\/\/doi.org\/10.1038\/s44325-026-00139-0","relation":{},"ISSN":["2948-2836"],"issn-type":[{"value":"2948-2836","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"27 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In this article the given name and the family names for the author 'Prof. Gregory Y. H. Lip' were incorrectly written as 'Gregory' and 'Y. H. Lip' respectively. The original article has been corrected.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G.Y.H.L.: Consultant and speaker for BMS\/Pfizer, Boehringer Ingelheim, Daiichi-Sankyo, Anthos. No fees are received personally. G.Y.H.L. is a National Institute for Health and Care Research (NIHR) Senior Investigator and co-principal investigator of the AFFIRMO project on multimorbidity in AF, which has received funding from the European Union\u2019s Horizon 2020 research and innovation program under grant agreement No 899871. Other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"37"}}